This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Original investigation
Contribution of obesity and cardiometabolic risk factors in patients with cardiovascular disease: A population based cohort study
Mohamad Ali Mansournia
Tehran University of Medical Sciences
Corresponding Author
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background
The mechanisms linking adiposity to associated clinical conditions such as type 2 diabetes, cardiovascular disease, and related metabolic and inflammatory disturbances. are poorly understood.This study aimed to identify sex-specific direct and indirect effects of central and general adiposity on cardiovascular disease, mediated by cardiometabolic risk factors and how much is independent of these factors.
Methods
We analyzed data from the TLGS cohort study with 6280 participants aged ≥ 30 years, free of cardiovascular disease at baseline with a median follow-up of 13.9 years. The total effects were broken down into natural direct and indirect effects using a 2-stage regression model in the context of the survival model. We also calculated the proportion mediated by systolic blood pressure, total serum cholesterol, and fasting plasma glucose as mediators.
Results
There was no interaction between BMI and its mediators in the multiplicative scale (P > 0.05 for all). Blood pressure was the most important mediator for general (HRNIE: 1.11, 95% CI:1.17–1.24) and central obesity (HRNIE: 1.11, 95% CI:1.07–1.15) with proportion mediated of 60% and 36% respectively in the total population. The percentage mediated through all three metabolic risk factors together was 46% (95% confidence interval = 31%-75%) for overweight, 66% (45%-100%) for general obesity and 52% (39%-87%) for central obesity. Blood pressure was the most important mediator for overweight and central adiposity in male population with 29% and 36% proportion mediated respectively while in female population percentage mediated through all three metabolic risk factors together was 23% (95% confidence interval = 13%-50%) for overweight, 36% (21%-64%) for general obesity and 52% (39%-87%) for central obesity.
Conclusions
Metabolic mediators explain more than 60% of the adverse effects of high BMI on CVD in the male population. Also, managing these metabolic mediators in women does not effectively contribute to reducing CVD risks without decreasing weight.
Keywords
Cardiovascular disease, mediator effects, survival model, direct and indirect effects
This is a list of supplementary files associated with this preprint. Click to download.
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 1
Posted 15 May, 2020
No community comments so far
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Learn more about our company.
This is a preprint. It has not completed peer review.
Original investigation
Contribution of obesity and cardiometabolic risk factors in patients with cardiovascular disease: A population based cohort study
Mohamad Ali Mansournia
Tehran University of Medical Sciences
Corresponding Author
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 1
Posted 15 May, 2020
No community comments so far
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background
The mechanisms linking adiposity to associated clinical conditions such as type 2 diabetes, cardiovascular disease, and related metabolic and inflammatory disturbances. are poorly understood.This study aimed to identify sex-specific direct and indirect effects of central and general adiposity on cardiovascular disease, mediated by cardiometabolic risk factors and how much is independent of these factors.
Methods
We analyzed data from the TLGS cohort study with 6280 participants aged ≥ 30 years, free of cardiovascular disease at baseline with a median follow-up of 13.9 years. The total effects were broken down into natural direct and indirect effects using a 2-stage regression model in the context of the survival model. We also calculated the proportion mediated by systolic blood pressure, total serum cholesterol, and fasting plasma glucose as mediators.
Results
There was no interaction between BMI and its mediators in the multiplicative scale (P > 0.05 for all). Blood pressure was the most important mediator for general (HRNIE: 1.11, 95% CI:1.17–1.24) and central obesity (HRNIE: 1.11, 95% CI:1.07–1.15) with proportion mediated of 60% and 36% respectively in the total population. The percentage mediated through all three metabolic risk factors together was 46% (95% confidence interval = 31%-75%) for overweight, 66% (45%-100%) for general obesity and 52% (39%-87%) for central obesity. Blood pressure was the most important mediator for overweight and central adiposity in male population with 29% and 36% proportion mediated respectively while in female population percentage mediated through all three metabolic risk factors together was 23% (95% confidence interval = 13%-50%) for overweight, 36% (21%-64%) for general obesity and 52% (39%-87%) for central obesity.
Conclusions
Metabolic mediators explain more than 60% of the adverse effects of high BMI on CVD in the male population. Also, managing these metabolic mediators in women does not effectively contribute to reducing CVD risks without decreasing weight.